Science Explorer Back to mapMap
Discussion
Topic · Surgery

Adrenal and Paraganglionic Tumors

Adrenal and Paraganglionic Tumors is a research topic within Surgery. Science Explorer counts 24k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the research related to pheochromocytoma and paraganglioma, including genetic mutations, clinical management, adrenal incidentalomas, biochemical diagnosis, succinate dehydrogenase, adrenocortical carcinoma, imaging characteristics, and molecular classification.

  • Pheochromocytoma
  • Paraganglioma
  • Genetic Mutations
  • Clinical Management
  • Adrenal Incidentaloma
  • Biochemical Diagnosis
  • Succinate Dehydrogenase
  • Adrenocortical Carcinoma
  • Imaging Characteristics
  • Molecular Classification
Research works
24k
fractional, since 1950
In the world top 10%
2.4k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+6%
the tick is no change
Largest producer
United States
32% of the 10 largest, 2022-now
Adrenal and Paraganglionic Tumors

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Adrenal and Paraganglionic Tumors research?

By volume, the United States and China publish the most (1k and 672 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1k works
  2. 2 China 672 works
  3. 3 India 267 works
  4. 4 Japan 254 works
  5. 5 Italy 226 works
  6. 6 Germany 171 works
  7. 7 Türkiye 151 works
  8. 8 Spain 147 works
  9. 9 France 137 works
  10. 10 United Kingdom 136 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.2%China: 21.1%India: 8.4%Japan: 8.0%6 others listed: 30.4%32%largest
United States1,026 · 32.2%China672 · 21.1%India267 · 8.4%Japan254 · 8.0%6 others listed969 · 30.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Adrenal and Paraganglionic Tumors research?

By volume in 2022-now, Mayo Clinic publishes the most Adrenal and Paraganglionic Tumors research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Harvard University.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 41 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 37 works
  3. 3 Harvard UniversityUnited States 34 works
  4. 4 National Institutes of HealthUnited States 32 works
  5. 5 All India Institute of Medical SciencesIndia 31 works
  6. 6 Tsinghua UniversityChina 30 works
  7. 7 Capital Medical UniversityChina 29 works
  8. 8 Sichuan UniversityChina 27 works
  9. 9 Shanghai Jiao Tong UniversityChina 26 works
  10. 10 Chongqing Medical UniversityChina 24 works

Who are the leading researchers in Adrenal and Paraganglionic Tumors?

The most-cited researchers publishing on Adrenal and Paraganglionic Tumors include Stacey L. Gabriel, Gad A. Getz and Elaine R. Mardis.

  1. 1 Stacey L. Gabriel United States 402k citations
  2. 2 Gad A. Getz United States 364k citations
  3. 3 Elaine R. Mardis United States 346k citations
  4. 4 Jun Wang China 340k citations
  5. 5 Gregory Y.H. Lip United Kingdom 311k citations
  6. 6 Richard A. Gibbs United States 292k citations
  7. 7 Matthew M. Meyerson United States 280k citations
  8. 8 Chris Sander United States 276k citations
  9. 9 Victoria Delgado Netherlands 269k citations
  10. 10 Gordon Brent Mills United States 265k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Adrenal and Paraganglionic Tumors?

The most cited paper in Adrenal and Paraganglionic Tumors is "1994 Consensus Conference on Acute GVHD Grading." (Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al., 1995), with 5,088 citations. Next come "Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway" (3,308) and "The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline" (2,957).

Most cited papers
#PaperReleasedCitations
1 1994 Consensus Conference on Acute GVHD Grading. Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al. · PubMed Jun 1995 5,088
2 Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway William G. Kaelin, Peter John Ratcliffe · Molecular Cell Open access May 2008 3,308
3 The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline John W. Funder, Robert M. Carey, Franco Mantero et al. · The Journal of Clinical Endocrinology & Metabolism Open access 2 Mar 2016 2,957
4 Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline Jacques W.M. Lenders, Quan‐Yang Duh, Graeme Eisenhofer et al. · The Journal of Clinical Endocrinology & Metabolism Open access Jun 2014 2,828
5 The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline Lynnette K. Nieman, Beverly M. K. Biller, James W. Findling et al. · The Journal of Clinical Endocrinology & Metabolism Open access 11 Mar 2008 2,727
All 100 most cited papers, with filters and sorting

Where is Adrenal and Paraganglionic Tumors research done?

The largest centres of Adrenal and Paraganglionic Tumors research in 2022-now are Beijing (China), Paris (France), Tokyo (Japan) and Shanghai (China).

Largest cities, 2022-now

  1. 1 BeijingChina 143 works
  2. 2 ParisFrance 56 works
  3. 3 TokyoJapan 56 works
  4. 4 ShanghaiChina 54 works
  5. 5 MoscowRussia 50 works
  6. 6 New YorkUnited States 46 works
  7. 7 São PauloBrazil 44 works
  8. 8 MadridSpain 43 works
  9. 9 IstanbulTürkiye 42 works
  10. 10 LondonUnited Kingdom 41 works
See Adrenal and Paraganglionic Tumors on the map

Where is the best place to study Adrenal and Paraganglionic Tumors?

Among universities, judged by research, University of Würzburg, Ludwig-Maximilians-Universität München and Karolinska Institutet score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 25.15%fractional works in this field (log) →share of work in the world top 10% →University of WürzburgUniversity of Naples…Ludwig-Maximilians-U…Karolinska Institutet
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of WürzburgGermany 74.934.8%15.0×19 -5.4%
2Ludwig-Maximilians-Universität MünchenGermany 72.628.7%6.7×23 +6.1%
3Karolinska InstitutetSweden 69.424.8%6.8×15 +45.7%
4University of Naples Federico IIItaly 67.234.5%4.8×14 +12.3%
5Harvard UniversityUnited States 63.420.1%2.7×34 -41.3%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 62.510.8%8.9×37 +28.7%
7Technische Universität DresdenGermany 62.134.0%4.6×10 +12.1%
8Chongqing Medical UniversityChina 60.218.1%10.5×24 +100.3%
9University of TurinItaly 60.129.0%6.3×14 -4.3%
10University of PennsylvaniaUnited States 59.116.7%4.7×20 +57.6%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Adrenal and Paraganglionic Tumors, country by country

Is Adrenal and Paraganglionic Tumors research growing?

Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Adrenal and Paraganglionic Tumors.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Adrenal and Paraganglionic Tumors as a percentage of every work published that year, 0.019% in 2024.

still counting0.020%0.040%Adrenal and Paraganglionic Tumors0.020% in 202519801990200020102020

Fractional works of Adrenal and Paraganglionic Tumors over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Adrenal and Paraganglionic Tumors10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Adrenal and Paraganglionic Tumors. Posts are plain text and can be reported.